Newsy's Latest Health News

The FDA has issued a warning about false positive results from rapid COVID-19 tests, particularly when instructions are not followed. These tests, which use nasal or throat swabs, are less accurate than molecular tests. The warning follows reports of false positives in nursing homes. In response to rising COVID-19 cases, Rhode Island's largest hospital system has restricted visits, with exceptions for certain patients. The report concludes with acknowledgments to Kaiser Health News.

What is the main concern the FDA has about rapid response COVID-19 tests?

• They are too expensive.

• They require specialized equipment.

• They can produce false positive results.

• They take too long to deliver results.

What is a key difference between rapid response tests and molecular tests?

• Rapid tests are more accurate.

• Molecular tests are less reliable.

• Molecular tests are faster.

• Rapid tests use nasal or throat swabs.

Why did the FDA issue a warning about rapid response tests?

• Due to their high cost.

• Because of reports of false positives in nursing homes.

• Because they are not widely available.

• Due to their complex usage instructions.

What action has Lifespan taken in response to rising COVID-19 cases?

• Increased the number of visitors allowed.

• Suspended most visits with some exceptions.

• Allowed only virtual visits.

• Closed all hospitals indefinitely.

Which hospital in Rhode Island allows one parent to visit at a time?

• The children's hospital.

• The maternity hospital.

• The emergency room.

• The general hospital.